Getz Pharma
Getz Pharma is a Pakistan-headquartered, privately held branded generic pharmaceutical manufacturer operating in 45+ countries with 8,000+ employees, producing affordable generic and biosimilar medicines across 13 therapeutic areas for emerging markets globally.
- Company typePrivate
- Founded1995
- HeadquartersKarachi, Pakistan
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Getz Pharma does
Getz Pharma (Private) Limited is a Pakistan-headquartered, privately held branded generic pharmaceutical manufacturer founded in 1995 and operating in 45+ countries with 8,000+ employees. The company develops, manufactures, and markets affordable medicines across 13 therapeutic areas — including cardiometabolic, gastroenterology, hepatology, pulmonology, urology, gynecology, oncology, pediatrics, orthopedics and rheumatology, infectious diseases, neuropsychiatry, general medicine, and nephrology — supported by a portfolio of 140+ developed molecules and 200+ branded generic products ranging from cardiovascular and diabetes therapies to monoclonal antibodies and dry-powder inhalers.
Manufacturing is anchored in Karachi at the LEED Platinum-certified Astola facility (South Asia's first pharma LEED Platinum plant), a dedicated fully segregated Cephalosporin and Carbapenem manufacturing plant, and the main head office in the Korangi Industrial Area. The facilities are GMP-approved by the World Health Organization (WHO Prequalification), the Pharmaceutical Inspection Co-operation Scheme (PIC/S), and the Eurasian Economic Union (EAEU), with ISO/IEC 17025:2017-accredited laboratories, bio-equivalence testing through US-FDA-accredited centers, and a dedicated MedVigi pharmacovigilance program. R&D capabilities span immediate/sustained/controlled-release and enteric-coated tablets, capsules, biologicals and biotech products, metered-dose inhalers, and injectables.
The business model is built on branded generic commercialization through wholly-owned regional subsidiaries and dedicated sales offices in markets including the UAE, Philippines, Nigeria, Kenya, Cambodia, Myanmar, Sri Lanka, Kazakhstan, and Pakistan's domestic market, supplemented by distributor networks into hospitals, clinics, and pharmacies. Recent moves include local biosimilar manufacturing of tirzepatide, semaglutide, and oral semaglutide (Oct 2025), a Daraz e-commerce direct-to-consumer partnership (Aug 2026), and an Estheticare collaboration for medical aesthetics (Nov 2025). The company is led by Executive Chairman Khalid Mahmood and Deputy Managing Director Zeeshan Ahmed, with no disclosed institutional or PE/VC ownership, and operates the MedOne medical education platform and NextLead early-careers program as ecosystem-buildout layers around the core pharma franchise.
Getz Pharma firmographics
Firmographics- Name
- Getz Pharma
- Legal name
- Getz Pharma (Private) Limited
- Website
- https://getzpharma.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Getz Pharma is a Pakistan-headquartered, privately held branded generic pharmaceutical manufacturer operating in 45+ countries with 8,000+ employees, producing affordable generic and biosimilar medicines across 13 therapeutic areas for emerging markets globally.
- Ownership category
- akta.pro rank
Getz Pharma industry classification
Industry- Product category
- Branded Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
- akta.pro secondary industries
- Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Respiratory & Allergy Pharmaceuticals (HLAIAAAH)
Keywords
Where Getz Pharma is headquartered
LocationHeadquarters
- HQ city
- Karachi
- HQ country
- Pakistan
- HQ region
- Asia
Offices11 records
Markets served
Getz Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Branded Generic Pharmaceuticals: Development, production, and marketing of branded generic medicines across 13 therapeutic areas including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Pharmaceutical products - pricing not publicly available |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Getz Pharma product offering
Product offeringCore offering
Getz Pharma develops, manufactures, and markets branded generic pharmaceutical products across 13 therapeutic areas including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopaedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology. Its portfolio includes tablets, capsules, biological/biotech products, metered dose inhalers, dry-powder inhalers, and injectable dosage forms, with more than 140 molecules developed and bio-equivalence testing from US-FDA accredited centers.
Product overview
Getz Pharma is an international research-driven, branded generic pharmaceutical company with operations in 45+ countries. The company manufactures and markets high-quality generic medicines across 13 therapeutic segments including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopaedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology. The portfolio includes over 200 branded generic products ranging from cardiovascular medications (Advant, Rovista, Trevia), diabetes treatments (Basagine, Dafo, Diampa, Sem-O, Sem-P, TIRZEE), anti-infectives, respiratory therapies (Prohaler, Fortide), oncology products (Trastuget), and specialty medicines. The company also operates MedOne, a medical education and collaboration platform hosting specialty forums for healthcare professionals.
Differentiator
Problem solved
Functional benefit
Brands
- MedOne: A dynamic platform uniting medical experts, researchers, and leaders to advance science, shape policy, and drive patient-centered care—especially in low- and middle-income countries. Features specialty forums including International Cardiometabolic Forum, International Urology Meeting, International Forum Infectious Diseases, International Psychiatry Forum, International Gastrointestinal and Hepatology Forum, and Public Health and Policy Forum.
- MedVigi
- NextLead
Products and services
- TIRZEE (Tirzepatide) Tirzepatide injection (GLP-1 and GIP receptor agonist) for the treatment of type 2 diabetes and obesity.
- Sem-O (Semaglutide) Semaglutide injection (GLP-1 receptor agonist) for diabetes treatment.
- Sem-P (Semaglutide)
Quantifiable outcome
- 140+ molecules developed across therapeutic areas
- +2 more outcomes
Companies that use Getz Pharma
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles2 records
Getz Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Getz Pharma partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- DarazcoreStrategic partnership with Pakistan's leading e-commerce platform for delivery of essential medicines within 24 to 72 hours across Pakistan. Combines Getz Pharma's pharmaceutical expertise with Daraz's digital reach and logistics infrastructure.
- EstheticareminorCollaboration for the debut of Tirzepatide in Islamabad, with Dr. Uzair Khan leading the initiative in the medical aesthetics sector in Pakistan.
- Tabba Heart InstitutecoreJoint venture for PAK-SEHAT research study - a 10-year nationwide longitudinal study focusing on assessing risk factors for coronary heart disease among young individuals under 40 years of age.
- Faysal FundsminorCollaboration for Financial Literacy Session for employees, providing practical knowledge on managing personal finances and investment opportunities.
- Indus Valley School of Art and Architecture (IVS)minorSupport for Critical Futures Conference 2025 on environmental sustainability and climate resilience in Pakistan, held at IVS Karachi.
Scale indicators7 records
Recent moves5 records
Expansion highlights6 records
Getz Pharma competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Customer concentration
Getz Pharma social profiles
Digital presenceGetz Pharma compliance and trust
Trust signalCompliance5 records
Getz Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Getz Pharma leadership team
Management profileNumber of profiles
Profiles8 records
Getz Pharma subsidiaries and ownership
Company hierarchySubsidiaries4 records
Getz Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Getz Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Getz Pharma
What does Getz Pharma do?
Getz Pharma develops, manufactures, and markets branded generic pharmaceutical products across 13 therapeutic areas including Cardiometabolic, Gastroenterology, Hepatology, Pulmonology, Urology, Gynecology, Oncology, Pediatrics, Orthopaedics & Rheumatology, Infectious Diseases, Neuropsychiatry, General Medicine, and Nephrology. Its portfolio includes tablets, capsules, biological/biotech products, metered dose inhalers, dry-powder inhalers, and injectable dosage forms, with more than 140 molecules developed and bio-equivalence testing from US-FDA accredited centers.
Is Getz Pharma a public or private company?
Getz Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Getz Pharma founded?
Getz Pharma was founded in 1995. It employs 1,001 to 5,000 people.
Where is Getz Pharma based?
Getz Pharma is headquartered in Karachi, Pakistan, in the Asia region.
How does Getz Pharma make money?
One revenue line is on record: branded Generic Pharmaceuticals.
Does Getz Pharma have an API?
No public API is recorded for Getz Pharma.
What industry is Getz Pharma in?
Getz Pharma's product category is Branded Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity). Its NAICS code is 325412 and its SIC code is 2834.